MedPath

Ceftadime

Brand Name: Ceftadime

Generic Name: Ceftazidime (As Pentahydrate)

Active
Registration Number

DR-XY48131

Dosage Form

Powder for Injection (IM/IV)

Issuance Date

July 1, 2022

Expiry Date

July 1, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength1 g
Packaging20 mL-capacity USP Type III clear glass vial with gray butyl rubber stopper and aluminum flip-off seal (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antibacterial (Third-generation cephalosporin)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Ceftazidime (As Pentahydrate)Active
Monograph: ceftazidime (as pentahydrate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform